Abstract
Psychostimulants and alcohol are widely abused substances with the adverse effects on global public health. Substance abuse seriously harms people's health and causes various diseases, especially neurodegenerative diseases. Neurodegenerative diseases include Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). The pathogenesis of neurodegenerative diseases is complex and diverse, usually involving oxidative stress, mitochondrial dysfunction, metal homeostasis disorder, and neuro-inflammation. The precise molecular mechanisms underlying neurodegeneration remain unclear, which is a major obstacle to therapeutic approaches. Therefore, it is urgent to improve the understanding of the molecular mechanisms of neurodegenerative processes and to identify the therapeutic targets for treatment and prevention. Ferroptosis is a regulatory cell necrosis caused by iron ion catalysis and lipid peroxidation induced by reactive oxygen species (ROS), which is thought to be associated with nervous system diseases, particularly neurodegenerative diseases. This review overviewed the ferroptosis process and explored the relationship of ferroptosis with substance abuse and neurodegenerative diseases, which provides a new way to study the molecular mechanisms of neurodegenerative diseases induced by alcohol, cocaine, and methamphetamine (MA), and also provides the potential therapeutic targets for substance abuse-induced neurodegenerative diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data sharing not applicable to this article as no datasets were generated during the current study.
References
Aaseth J, Skalny AV, Roos PM et al (2021) Copper, iron, selenium and lipo-glycemic dysmetabolism in Alzheimer’s disease. Int J Mol Sci 22:9461. https://doi.org/10.3390/ijms22179461
Adisetiyo V, McGill CE, DeVries WH et al (2019) Elevated brain iron in cocaine use disorder as indexed by magnetic field correlation imaging. Biol Psychiatry Cogn Neurosci Neuroimaging 4:579–588. https://doi.org/10.1016/j.bpsc.2018.11.006
Aharonovich E, Nunes E, Hasin D (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 71:207–211. https://doi.org/10.1016/S0376-8716(03)00092-9
Argyriou AA, Karanasios P, Makridou A et al (2011) Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis. Neurodegener Dis 8:146–148. https://doi.org/10.1159/000318084
Ayton S, Wang Y, Diouf I et al (2020) Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry 25:2932–2941. https://doi.org/10.1038/s41380-019-0375-7
Bao W-D, Pang P, Zhou X-T et al (2021) Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ 28:1548–1562. https://doi.org/10.1038/s41418-020-00685-9
Barbosa DJ, Capela JP, Feio-Azevedo R et al (2015) Mitochondria: key players in the neurotoxic effects of amphetamines. Arch Toxicol 89:1695–1725. https://doi.org/10.1007/s00204-015-1478-9
Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for therapeutics. J Neurochem 139:179–197. https://doi.org/10.1111/jnc.13425
Belaidi AA, Gunn AP, Wong BX et al (2018) Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice. Neurotherapeutics 15:1055–1062. https://doi.org/10.1007/s13311-018-0656-x
Bersuker K, Hendricks JM, Li Z et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688–692. https://doi.org/10.1038/s41586-019-1705-2
Biagioni F, Ferese R, Limanaqi F et al (2019) Methamphetamine persistently increases alpha-synuclein and suppresses gene promoter methylation within striatal neurons. Brain Res 1719:157–175. https://doi.org/10.1016/j.brainres.2019.05.035
Binolfi A, Limatola A, Verzini S et al (2016) Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites. Nat Commun 7:10251. https://doi.org/10.1038/ncomms10251
Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y (2016) Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci 41:274–286. https://doi.org/10.1016/j.tibs.2015.11.012
Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162–172. https://doi.org/10.1056/NEJMra1603471
Callaghan RC, Cunningham JK, Sykes J, Kish SJ (2012) Increased risk of Parkinson’s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 120:35–40. https://doi.org/10.1016/j.drugalcdep.2011.06.013
Chen L, Zhou L, Yu P et al (2019) Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: the roles of insulin signaling in SH-SY5Y cell line. J Toxicolog Sci 44:493–503. https://doi.org/10.2131/jts.44.493
Chen X, Yu C, Kang R, Tang D (2020) Iron metabolism in ferroptosis. Front Cell Dev Biol 8:1
Chen L, Na R, Danae McLane K et al (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep 11:1–13. https://doi.org/10.1038/s41598-021-92369-8
Cheng J, Liao Y, Dong Y et al (2020) Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy 16:2193–2205. https://doi.org/10.1080/15548627.2020.1719723
Clark KH, Wiley CA, Bradberry CW (2013) Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res 23:174–188. https://doi.org/10.1007/s12640-012-9334-7
Costa BM, Yao H, Yang L, Buch S (2013) Role of endoplasmic reticulum (ER) stress in cocaine-induced microglial cell death. J Neuroimmune Pharmacol 8:705–714. https://doi.org/10.1007/s11481-013-9438-8
Crews F (2012) Inflammasome-IL-1β signaling mediates ethanol inhibition of hippocampal neurogenesis. Front Neurosci 6:1
Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12–R20. https://doi.org/10.1093/hmg/ddq160
Dai C, Kong B, Qin T et al (2022) Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation. Toxicology 465:153055. https://doi.org/10.1016/j.tox.2021.153055
de Farias CC, Maes M, Bonifácio KL et al (2016) Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: disease and staging biomarkers and new drug targets. Neurosci Lett 617:66–71. https://doi.org/10.1016/j.neulet.2016.02.011
de la Monte SM, Kril JJ (2014) Human alcohol-related neuropathology. Acta Neuropathol 127:71–90. https://doi.org/10.1007/s00401-013-1233-3
Devos D, Moreau C, Kyheng M et al (2019) A ferroptosis-based panel of prognostic biomarkers for amyotrophic lateral sclerosis. Sci Rep 9:2918. https://doi.org/10.1038/s41598-019-39739-5
Dietrich JB (2009) Alteration of blood–brain barrier function by methamphetamine and cocaine. Cell Tissue Res 336:385–392. https://doi.org/10.1007/s00441-009-0777-y
Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Doll S, Freitas FP, Shah R et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575:693–698. https://doi.org/10.1038/s41586-019-1707-0
Doyle KM, Kennedy D, Gorman AM et al (2011) Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med 15:2025–2039. https://doi.org/10.1111/j.1582-4934.2011.01374.x
Drummond E, Pires G, MacMurray C et al (2020) Phosphorylated tau interactome in the human Alzheimer’s disease brain. Brain 143:2803–2817. https://doi.org/10.1093/brain/awaa223
Evans RC, Chen L, Na R et al (2022) The Gpx4NIKO mouse is a versatile model for testing interventions targeting ferroptotic cell death of spinal motor neurons. Neurotox Res 40:373–383. https://doi.org/10.1007/s12640-021-00469-0
Fein G, Meyerhoff DJ (2000) Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer. Alcohol Clin Exp Res 24:1227–1235. https://doi.org/10.1111/j.1530-0277.2000.tb02088.x
Feng H, Schorpp K, Jin J et al (2020) Transferrin receptor is a specific ferroptosis marker. Cell Rep 30:3411-3423.e7. https://doi.org/10.1016/j.celrep.2020.02.049
Fernández-Mendívil C, Luengo E, Trigo-Alonso P et al (2021) Protective role of microglial HO-1 blockade in aging: implication of iron metabolism. Redox Biol 38:101789. https://doi.org/10.1016/j.redox.2020.101789
Ferrucci M, Pasquali L, Paparelli A et al (2008) Pathways of methamphetamine toxicity. Ann N Y Acad Sci 1139:177–185. https://doi.org/10.1196/annals.1432.013
Fiala M, Eshleman AJ, Cashman J et al (2005) Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol 11:281–291. https://doi.org/10.1080/13550280590952835
Galaris D, Barbouti A, Pantopoulos K (2019) Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta (BBA) Mol Cell Res 1866:118535. https://doi.org/10.1016/j.bbamcr.2019.118535
Granado N, Ares-Santos S, Moratalla R (2013) Methamphetamine and Parkinson’s disease. Parkinsons Dis 2013:308052. https://doi.org/10.1155/2013/308052
Haorah J, Rump TJ, Xiong H (2013) Reduction of brain mitochondrial β-oxidation impairs complex I and V in chronic alcohol intake: the underlying mechanism for neurodegeneration. PLoS ONE 8:e70833. https://doi.org/10.1371/journal.pone.0070833
Hassannia B, Vandenabeele P, Vanden Berghe T (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35:830–849. https://doi.org/10.1016/j.ccell.2019.04.002
Hernández JA, López-Sánchez RC, Rendón-Ramírez A (2016) Lipids and oxidative stress associated with ethanol-induced neurological damage. Oxid Med Cell Longevity 2016:e1543809. https://doi.org/10.1155/2016/1543809
Herrando-Grabulosa M, Gaja-Capdevila N, Vela JM, Navarro X (2021) Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. Br J Pharmacol 178:1336–1352. https://doi.org/10.1111/bph.15224
Hillemacher T, Bachmann O, Kahl KG, Frieling H (2018) Alcohol, microbiome, and their effect on psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 85:105–115. https://doi.org/10.1016/j.pnpbp.2018.04.015
Hoffman JL, Faccidomo S, Kim M et al (2019) Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer’s disease. Int Rev Neurobiol 148:169–230
Hogarth P (2015) Neurodegeneration with brain iron accumulation: diagnosis and management. JMD 8:1–13. https://doi.org/10.14802/jmd.14034
Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565–581. https://doi.org/10.1038/s41582-019-0244-7
Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266–282. https://doi.org/10.1038/s41580-020-00324-8
Kamal H, Tan GC, Ibrahim SF et al (2020) Alcohol use disorder, neurodegeneration, Alzheimer’s and Parkinson’s disease: interplay between oxidative stress, neuroimmune response and excitotoxicity. Front Cell Neurosci. https://doi.org/10.3389/fncel.2020.00282
Kempuraj D, Thangavel R, Natteru P et al (2016) Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine 1:1003
Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, Kössl J, Brandner S, Daniels JD, Schmitt-Kopplin P, Hauck SM, Stockwell BR, Hadian K, Schick JA (2020) GTP Cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci 6:41–53. https://doi.org/10.1021/acscentsci.9b01063
Kwan JY, Jeong SY, Van Gelderen P, Deng H-X, Quezado MM, Danielian LE, Butman JA, Chen L, Bayat E, Russell J, Siddique T, Duyn JH, Rouault TA, Floeter MK (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS ONE 7:e35241. https://doi.org/10.1371/journal.pone.0035241
Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9:42. https://doi.org/10.1186/s40035-020-00221-2
Lane CA, Hardy J, Schott JM (2018) Alzheimer’s disease. Eur J Neurol 25:59–70. https://doi.org/10.1111/ene.13439
Liu S, Sarkar C, Dinizo M et al (2015) Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death. Cell Death Dis 6:e1582–e1582. https://doi.org/10.1038/cddis.2014.527
Mao C, Liu X, Zhang Y et al (2021) DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593:586–590. https://doi.org/10.1038/s41586-021-03539-7
Melega WP, Laćan G, Harvey DC, Way BM (2007) Methamphetamine increases basal ganglia iron to levels observed in aging. NeuroReport 18:1741–1745. https://doi.org/10.1097/WNR.0b013e3282f0d4f4
Muñiz-Hernández S (2012) Alcoholism: common and oxidative damage biomarkers. J Clin Toxicol. https://doi.org/10.4172/2161-0495.S7-006
Nguyen X-KT, Lee J, Shin E-J et al (2015) Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene. J Pineal Res 58:86–106. https://doi.org/10.1111/jpi.12195
Nordahl TE, Salo R, Leamon M (2003) Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. JNP 15:317–325. https://doi.org/10.1176/jnp.15.3.317
Otasevic V, Vucetic M, Grigorov I et al (2021) Ferroptosis in different pathological contexts seen through the eyes of mitochondria. Oxid Med Cell Longevity 2021:e5537330. https://doi.org/10.1155/2021/5537330
Park M-J, Lee S-K, Lim M-A et al (2006) Effect of α-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity. Brain Res 1109:176–182. https://doi.org/10.1016/j.brainres.2006.06.030
Park H, Kam T-I, Peng H et al (2022) PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s disease. Cell 185:1943-1959.e21. https://doi.org/10.1016/j.cell.2022.04.020
Paulus MP, Stewart JL (2020) Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: a review. JAMA Psychiat 77:959–966. https://doi.org/10.1001/jamapsychiatry.2020.0246
Pelkonen A, Hiltunen M, Kiianmaa K, Yavich L (2010) Stimulated dopamine overflow and alpha-synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference. J Neurochem 114:1168–1176. https://doi.org/10.1111/j.1471-4159.2010.06844.x
Periyasamy P, Guo M-L, Buch S (2016) Cocaine induces astrocytosis through ER stress-mediated activation of autophagy. Autophagy 12:1310–1329. https://doi.org/10.1080/15548627.2016.1183844
Pyatigorskaya N, Sharman M, Corvol J-C et al (2015) High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Move Disord 30:1077–1084. https://doi.org/10.1002/mds.26218
Qin Y, Ouyang Q, Pablo J, Mash DC (2005) Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. NeuroReport 16:1489. https://doi.org/10.1097/01.wnr.0000175617.39054.ba
Quigley EMM (2017) Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 17:94. https://doi.org/10.1007/s11910-017-0802-6
Rouault TA (2013) Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14:551–564. https://doi.org/10.1038/nrn3453
Rui T, Wang H, Li Q et al (2021) Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury-induced ferroptosis. J Pineal Res. https://doi.org/10.1111/jpi.12704
Sajja RK, Rahman S, Cucullo L (2016) Drugs of abuse and blood–brain barrier endothelial dysfunction: a focus on the role of oxidative stress. J Cereb Blood Flow Metab 36:539–554. https://doi.org/10.1177/0271678X15616978
Shi-Jie L, Zheng-Yu F, Ying Y et al (2003) Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo. Acta Pharmacol Sin 7:1
Shukla M, Vincent B (2020) The multi-faceted impact of methamphetamine on Alzheimer’s disease: from a triggering role to a possible therapeutic use. Ageing Res Rev 60:101062. https://doi.org/10.1016/j.arr.2020.101062
Singal AK, Mathurin P (2021) Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA 326:165–176. https://doi.org/10.1001/jama.2021.7683
Song T, Song X, Zhu C et al (2021) Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev 72:101503. https://doi.org/10.1016/j.arr.2021.101503
Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609–622. https://doi.org/10.1016/S1474-4422(13)70090-5
Stockwell BR, Jiang X, Gu W (2020) Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol 30:478–490. https://doi.org/10.1016/j.tcb.2020.02.009
Toborek M, Seelbach MJ, Rashid CS et al (2013) Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier. Mol Neurodegener 8:22. https://doi.org/10.1186/1750-1326-8-22
Topiwala A, Allan CL, Valkanova V et al (2017) Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ. https://doi.org/10.1136/bmj.j2353
Tsatsanis A, Wong BX, Gunn AP et al (2020) Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention. Mol Psychiatry 25:1958–1966. https://doi.org/10.1038/s41380-020-0762-0
Van Do B, Gouel F, Jonneaux A et al (2016) Ferroptosis, a newly characterized form of cell death in Parkinson’s disease that is regulated by PKC. Neurobiol Dis 94:169–178. https://doi.org/10.1016/j.nbd.2016.05.011
Walker J, Winhusen T, Storkson JM et al (2014) Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study. Hum Psychopharmacol Clin Exp 29:537–543. https://doi.org/10.1002/hup.2430
Wan W, Cao L, Kalionis B et al (2019) Iron deposition leads to hyperphosphorylation of tau and disruption of insulin signaling. Front Neurol 10:1
Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https://doi.org/10.1186/s40035-015-0042-0
Weiland A, Wang Y, Wu W et al (2019) Ferroptosis and its role in diverse brain diseases. Mol Neurobiol 56:4880–4893. https://doi.org/10.1007/s12035-018-1403-3
Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease—a double-edged sword. Neuron 35:419–432. https://doi.org/10.1016/S0896-6273(02)00794-8
Xiao Z, Yan Z, Sun X et al (2022) MiR-9-5p inhibits the MMP+-induced neuron apoptosis through regulating SCRIB/β-catenin signaling in Parkinson’s disease. Oxid Med Cell Longevity 2022:e9173514. https://doi.org/10.1155/2022/9173514
Xu Y, Zhang Y, Zhang J-H et al (2020) Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP/PS1 mice. Free Radical Biol Med 158:84–95. https://doi.org/10.1016/j.freeradbiomed.2020.07.012
Yang Y, Wang Y, Guo L et al (2022) Interaction between macrophages and ferroptosis. Cell Death Dis 13:355. https://doi.org/10.1038/s41419-022-04775-z
Yu C, Kim B, Kim E (2016) FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ 23:1873–1885. https://doi.org/10.1038/cdd.2016.99
Yu X, Wang T, Chen Y et al (2020) Alcohol drinking and amyotrophic lateral sclerosis: an instrumental variable causal inference. Ann Neurol 88:195–198. https://doi.org/10.1002/ana.25721
Zhang S, Wang Z, Cai F et al (2017) BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer’s pathogenesis. J Neurosci 37:6915–6925. https://doi.org/10.1523/JNEUROSCI.0340-17.2017
Zheng J, Conrad M (2020) The metabolic underpinnings of ferroptosis. Cell Metab 32:920–937. https://doi.org/10.1016/j.cmet.2020.10.011
Acknowledgements
Thanks to National Natural Science Foundation of China (No. 81973404) and Natural Science Foundation of Liaoning Province (No. 2022-MS-224) for supporting this work.
Author information
Authors and Affiliations
Contributions
Conceptualization: CG, LC, and YW; Funding acquisition: YW; Writing—original draft: CG; Writing—review and editing: LC and YW. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no financial or non-financial conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guo, C., Chen, L. & Wang, Y. Substance abuse and neurodegenerative diseases: focus on ferroptosis. Arch Toxicol 97, 1519–1528 (2023). https://doi.org/10.1007/s00204-023-03505-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-023-03505-4